1Watanabe Y,Tahara K,Hirai A,et al.Subtypes of ani -TSH receptor antibodies classified by various assays using CHO cells expressing wild-type or chimeric human TSH receptor[].Thyroid.1997
2Akamizu T,Moriyama K,Miura M,et al.Characterization of combinant monoclonal antithyrotropin receptor antibodies (TSHRAbs) derived from lymphocytes of patients with Graves disease: epitope and binding study of two stimulatory TSHRAbs[].The Journal of Endocrinology.1999
3Akamizu T,Kohn LD,Hiratani H,et al.Hashimoto’ s thyroiditis with heterogeneous antithyrotropin receptor antibodies: unique epitopes may contribute to the regulation of thyroid function by the antibodies[].The Journal of Clinical Endocrinology.2000
4Meller J,Jauho A,Hufner M,et al.Disseminated thyroid autonomy or Graves’ disease: revaluation by a second generation TSH receptor antibody assay[].Thyroid.2000
5Morgenthaler NG,Pampel I,Aust G.Application of a bioassay with CHO cells for the routine detection of stimulating and blocking autoantibodies to the TSHreceptor[].Hormone and Metabolic Research.1998
6Giordabo C,Stassi G,De Mria R,et al.Potential involve, ent of Fas and its ligand in the pathogenesis of Hashimoto’ s thyroiditis[].Science.1997
7Noh JY,Hamada N,Inoue Y,et al.Thyroid-stimulating antibody is related to Graves’ ophthalmopathy,but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves′disease[].Thyroid.2000
8Khoo DH,Ho SC,Seah LL,et al.The combination of absent thyroid peroxidase antibodies and high thyroidstimulating immunoglobulin levels in Graves’ disease identifies a group at markedly increased risk of ophthalmopathy[].Thyroid.1999
9Gerding MN,van der Meer JW,Broenink M,et al.Association of thyrotrophin receptor antibodies with the clinical features of Graves’ ophthalmopathy[].Clinical Endocrinology.2000
